Wednesday, 11 March 2009
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR
Fine
The FINE blog keeps you up-to-date on the pharmaceutical fine chemical and custom manufacturing sector. The weekly FINE Newsletter gives senior pharmaceutical fine chemical and custom manufacturing leaders a weekly summary of the key news stories and trends for the sector. The FINE Newsletter and blog focus on coverage of companies in the pharmaceutical fine chemical custom manufacturing sector, without forgetting key news from their customers in the pharma industry.
Subscribe
To receive the newsletter, each week, please subscribe.
Advertising
|
|
|
|
||
| Read this FREE online! Full Book | PDF Summary | Podcast | ||
Blog Archive
-
▼
2009
(368)
-
▼
March
(36)
- FDA Deputy Commissioner, Joshua Sharfstein will be...
- Biosimilars bill introduced in US Senate
- Cobra Biomanufacturing sees improved H2 in 2008, a...
- Consortium wins manufacturing technology grant
- Pharma industry calls for FDA food-drug split
- Cobra Biomanufacturing reaches agreement with cust...
- Chemtura files for bankruptcy protection
- DSM to establish JVs in China
- Almac has "topped-off" it new headquaters site in ...
- Wacker expects fine chemicals growth in 2009
- Onyx Scientific, Cyprotex Discovery and Glytech wi...
- Novasep to build HPAI facility
- Obama announces FDA picks
- Cobra Biomanufacturing customer in discussions to ...
- Rudolf Hanko is to take over as CEO of Siegfried f...
- BASF to sell-off business unites to get EU approva...
- Roche finally gets Genentech - for $46.8bn
- Obama settles on FDA choices
- Dow and Rohm & Haas settle merger disagreement
- Ampac Fine Chemicals has inaugurated its kilogram ...
- Lonza speeds biologics development timeline
- Dow back in talks with Rohm & Haas
- UKTI seeks companies for ChemSpec Europe
- Merck to acquire Schering Plough for $41.1bn
- DSM and Roquette are to commercialise a bio-based ...
- Penn Pharmaceuticals has launched a £12m, 5-year e...
- US Senators propose clamp down on unsafe drug imports
- Lonza to manufacture TcL Pharma antibody
- RFCL-Mallinkrodt Baker deal off
- Dow considers selling assets to fund Rohm & Haas deal
- Novacta and CML partner for chiral processes
- India to be top five pharma hub
- Lonza leases 2200m2 space in Hopkinton, MA
- Ranbaxy lab falsifies data
- Fine Organics plans 5% sales growth
- Lonza to manufacture Opsona antibody
-
▼
March
(36)
Technorati
Copyright ©2007, 2008 FINE. All rights reserved.
No comments:
Post a Comment